Woodline Partners LP

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,660,013

+$798,004 QoQ

Shares Held

200,001

0.0% QoQ

Ownership

0.277%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#40

of 158 holders

Holding Since

Dec 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. FDMT ranks #160 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,660,013	200,001	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,862,009	200,001	0.0%	Shares	Sole	2026-05-15
2025-12-31	$1,500,007	200,001	+51.4%	Shares	Sole	2026-02-17
2021-12-31	$2,898,646	132,117	+52.9%	Shares	Sole	2022-02-14
2021-09-30	$2,330,828	86,423	+123.3%	Shares	Sole	2021-11-15
2021-06-30	$932,088	38,708	-54.9%	Shares	Sole	2021-08-16
2021-03-31	$3,723,262	85,829	-17.0%	Shares	Sole	2021-05-17
2020-12-31	$4,288,126	103,453	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.